OTCPK:NVLP.F

Stock Analysis Report

Executive Summary

Nova Leap Health Corp. provides personal home care and support services in the United States and Canada.

Snowflake

Fundamentals

Mediocre balance sheet and overvalued.

Risks

  • Nova Leap Health is not covered by any analysts.

Share Price & News

How has Nova Leap Health's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

NVLP.F

-0.04%

US Healthcare

-0.6%

US Market


1 Year Return

n/a

NVLP.F

-9.1%

US Healthcare

0.6%

US Market

No trading data on NVLP.F.

No trading data on NVLP.F.


Share holder returns

NVLP.FIndustryMarket
7 Day0%-0.04%-0.6%
30 Day-4.9%-0.5%2.2%
90 Day-7.2%-1.6%1.1%
1 Yearn/a-7.7%-9.1%2.9%0.6%
3 Yearn/a29.6%24.3%44.6%35.2%
5 Yearn/a66.1%56.2%61.9%44.2%

Price Volatility Vs. Market

How volatile is Nova Leap Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Nova Leap Health undervalued based on future cash flows and its price relative to the stock market?

1.9x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Nova Leap Health to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Nova Leap Health to establish if it is available at substantial discount.


Price Based on Earnings

Nova Leap Health is loss making, we can't compare its value to the US Healthcare industry average.

Nova Leap Health is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Nova Leap Health, we can't assess if its growth is good value.


Price Based on Value of Assets

Nova Leap Health is good value based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Nova Leap Health expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

11.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nova Leap Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of NVLP.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Nova Leap Health's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Nova Leap Health performed over the past 5 years?

6.5%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Nova Leap Health does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.

Unable to compare Nova Leap Health's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Nova Leap Health's 1-year growth to the US Healthcare industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Nova Leap Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Nova Leap Health has efficiently used its assets last year compared to the US Healthcare industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Nova Leap Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Nova Leap Health's financial position?


Financial Position Analysis

Nova Leap Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Nova Leap Health's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Nova Leap Health's level of debt (63%) compared to net worth is high (greater than 40%).

Unable to establish if Nova Leap Health's debt level has increased without past 5-year debt data.


Balance Sheet

Low level of unsold assets.

Debt is not covered by short term assets, assets are 0.6x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Nova Leap Health has sufficient cash runway for more than 3 years based on current free cash flow.

Nova Leap Health has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 22.3% each year.


Next Steps

Dividend

What is Nova Leap Health's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Nova Leap Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Nova Leap Health's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Nova Leap Health has not reported any payouts.

Unable to verify if Nova Leap Health's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Nova Leap Health has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Nova Leap Health's salary, the management and board of directors tenure and is there insider trading?

2.9yrs

Average board tenure


CEO

Chris Dobbin (44yo)

0yrs

Tenure

US$340,000

Compensation

Mr. Christopher Donald Dobbin, also known as Chris, CPA, CA, serves as the Chief Executive Officer and President of Nova Leap Health Corp. and served as its Chief Financial Officer until October 2016. Mr.  ...


CEO Compensation Analysis

Chris's remuneration is lower than average for companies of similar size in United States of America.

Chris's compensation has increased whilst company is loss making.


Board Age and Tenure

2.9yrs

Average Tenure

44yo

Average Age

The average tenure for the Nova Leap Health board of directors is less than 3 years, this suggests a new board.


Insider Trading

More shares have been bought than sold by Nova Leap Health individual insiders in the past 3 months, but not in substantial volumes.


Recent Insider Transactions

BuyUS$9,86018 Jul 19
Dana Hatfield
EntityIndividual
Role
Chairman of the Board
Chairman of the Board
Shares50,000
Max PriceUS$0.21
BuyUS$1,04905 Jul 19
Michael O'Keefe
EntityIndividual
Role
Member of the Board of Directors
Director
Shares5,000
Max PriceUS$0.21
BuyUS$3,38328 Jun 19
Christopher Dobbin
EntityIndividual
Role
Chief Executive Officer
CEO, President & Director
Shares15,000
Max PriceUS$0.23
BuyUS$6,48628 Jun 19
Michael O'Keefe
EntityIndividual
Role
Member of the Board of Directors
Director
Shares30,000
Max PriceUS$0.22
BuyUS$5,60505 Apr 19
Megan Spidle
EntityIndividual
Role
Chief Financial Officer
CFO & Corporate Secretary
Shares25,000
Max PriceUS$0.22
BuyUS$66,33606 Feb 19
Norman Fulcher
EntityIndividual
Shares250,000
Max PriceUS$0.27
BuyUS$8,73919 Dec 18
Wayne Myles
EntityIndividual
Role
Member of the Board of Directors
Director
Shares40,500
Max PriceUS$0.22
BuyUS$2,89618 Dec 18
Christopher Dobbin
EntityIndividual
Role
Chief Executive Officer
CEO, President & Director
Shares13,000
Max PriceUS$0.22
BuyUS$5,13718 Dec 18
Wayne Myles
EntityIndividual
Role
Member of the Board of Directors
Director
Shares21,000
Max PriceUS$0.25
BuyUS$14,09614 Dec 18
Wayne Myles
EntityIndividual
Role
Member of the Board of Directors
Director
Shares59,000
Max PriceUS$0.24
BuyUS$16,91911 Dec 18
Wayne Myles
EntityIndividual
Role
Member of the Board of Directors
Director
Shares75,500
Max PriceUS$0.24
BuyUS$73911 Dec 18
Christopher Dobbin
EntityIndividual
Role
Chief Executive Officer
CEO, President & Director
Shares3,000
Max PriceUS$0.25
BuyUS$29,58306 Dec 18
Wayne Myles
EntityIndividual
Role
Member of the Board of Directors
Director
Shares134,500
Max PriceUS$0.22
BuyUS$91530 Nov 18
Christopher Dobbin
EntityIndividual
Role
Chief Executive Officer
CEO, President & Director
Shares4,200
Max PriceUS$0.22
BuyUS$20,08629 Oct 18
Michael O'Keefe
EntityIndividual
Role
Member of the Board of Directors
Director
Shares75,000
Max PriceUS$0.27
BuyUS$33,84528 Sep 18
Dana Hatfield
EntityIndividual
Role
Chairman of the Board
Chairman of the Board
Shares125,000
Max PriceUS$0.27

Ownership Breakdown


Management Team

  • Megan Spidle (42yo)

    CFO & Corporate Secretary

    • Tenure: 2.9yrs
    • Compensation: US$220.00k
  • Chris Dobbin (44yo)

    CEO, President & Director

    • Tenure: 0yrs
    • Compensation: US$340.00k
  • Michael Gremley

    Manager of Corporate Development

    • Tenure: 0yrs

Board Members

  • Mike O'Keefe (46yo)

    Director

    • Tenure: 3.8yrs
    • Compensation: US$23.00k
  • Dana Hatfield (43yo)

    Chairman of the Board

    • Tenure: 0yrs
    • Compensation: US$36.00k
  • Chris Dobbin (44yo)

    CEO, President & Director

    • Tenure: 0yrs
    • Compensation: US$340.00k
  • Wayne Myles

    Director

    • Tenure: 2yrs
    • Compensation: US$18.00k
  • Mike O’Keefe

    Director

    • Tenure: 0.3yrs

Company Information

Nova Leap Health Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Nova Leap Health Corp.
  • Ticker: NVLP.F
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$17.087m
  • Listing Market Cap: CA$12.884m
  • Shares outstanding: 61.02m
  • Website: https://novaleaphealth.com

Location

  • Nova Leap Health Corp.
  • 7071 Bayers Road
  • Suite 5003
  • Halifax
  • Nova Scotia
  • B3L 2C2
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NLHTSXV (TSX Venture Exchange)YesCommon SharesCACADApr 2016
NVLP.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDApr 2016

Biography

Nova Leap Health Corp. provides personal home care and support services in the United States and Canada. Its services include companionship; cooking and meal preparation; dementia care; light housekeeping; ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/22 00:50
End of Day Share Price2019/09/13 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.